Skip to main content
PIRAMAL PHARMA LIMITED logo

PIRAMAL PHARMA LIMITED — Investor Relations & Filings

Ticker · PPLPHARMA ISIN · INE0DK501011 LEI · 3358006D6AL7PZ4U9T51 BSE.NS Manufacturing
Open in API
Filings indexed 367 across all filing types
Latest filing 2023-07-28 Regulatory Filings
Country IN India
Listing BSE.NS PPLPHARMA

About PIRAMAL PHARMA LIMITED

https://www.piramalpharma.com/

Piramal Pharma Limited provides a broad range of products and services across the drug lifecycle through three main business segments: Piramal Pharma Solutions, Piramal Critical Care, and Consumer Healthcare. Piramal Pharma Solutions operates as an integrated Contract Development and Manufacturing Organization (CDMO), offering end-to-end services from drug discovery and development to commercial manufacturing of APIs and formulations. Piramal Critical Care focuses on complex hospital generics, holding a significant global market share in inhalation anesthetics, including Sevoflurane and Isoflurane, as well as injectable anesthesia and pain management therapies. The Consumer Healthcare division manages a diverse portfolio of over-the-counter brands such as Saridon, Lacto Calamine, and Tetmosol. The company leverages an extensive global manufacturing network to deliver specialized healthcare solutions worldwide.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 28th July 2023 addressed to stock exchanges regarding the upcoming Board Meeting on 3rd August 2023 to consider the unaudited financial results for the quarter ended 30th June 2023. It references regulatory compliance under SEBI Listing Regulations (Regulation 29 and 50) and mentions the closure of the trading window. The document does not contain any actual financial data or detailed financial statements but is an advance notice of the board meeting where the quarterly results will be considered. The length is only 1661 characters, indicating it is a brief announcement rather than a full report. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about an upcoming event and not the financial report itself.
2023-07-28 English
Committee Meeting Updates
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Piramal Pharma Limited regarding the outcome of a Committee of Directors meeting about a Rights Issue. It details the terms of the Rights Issue, including the number of shares, price, record date, and other procedural information. The document references compliance with SEBI Listing Regulations and provides specifics about the rights entitlement and related arrangements. It does not contain financial statements or detailed financial analysis but rather announces the capital raising activity and its terms. Therefore, this document fits the category of a Capital/Financing Update (CAP). The document length is about 4694 characters, which is sufficient for a detailed announcement but not a full financial report. Hence, the classification is CAP with high confidence.
2023-07-27 English
Committee Meeting Updates
Capital/Financing Update Classification · 95% confidence The document is a notice about a meeting of the Committee of Directors regarding a Rights Issue of equity shares. It references regulatory compliance under SEBI Listing Regulations and details the agenda to consider terms of the Rights Issue such as price, entitlement ratio, and record date. The document is short (2184 characters) and serves as an announcement of an upcoming meeting related to capital raising activities. It does not contain financial statements or detailed financial data, nor is it a full report. Therefore, it fits the category of Capital/Financing Update (CAP).
2023-07-24 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a letter dated 7th July 2023 addressed to stock exchanges (BSE and NSE) regarding the publication of a newspaper advertisement for the Notice of the 3rd Annual General Meeting (AGM) of Piramal Pharma Limited. It specifically mentions the newspaper advertisement titled 'Notice of the 3rd Annual General Meeting and e-voting information'. The content is an intimation under SEBI Listing Regulations about the AGM notice publication, not the AGM materials themselves. The document is about announcing the notice and e-voting details, which fits the category of AGM Information (AGM-R). The document length is 15,000 characters, but the content is clearly an announcement/intimation about the AGM notice, not the full AGM presentation or materials. Therefore, the correct classification is AGM Information (AGM-R) with high confidence.
2023-07-07 English
Updates
Environmental & Social Information Classification · 95% confidence The document is a detailed Business Responsibility & Sustainability Report for the financial year 2022-23, submitted pursuant to SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It includes extensive disclosures on corporate social responsibility (CSR), sustainability practices, employee data, risk management related to business ethics, data privacy, and product quality. The report is part of the Annual Report for the financial year 2022-23, as explicitly stated in the text. The length of the document (15,000 characters) and the detailed content indicate it is the report itself, not merely an announcement or a certification. The focus on environmental, social, and governance factors aligns with the definition of Environmental & Social Information (SR). Therefore, the document should be classified as Environmental & Social Information (SR).
2023-07-06 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a detailed notice and advertisement related to the Annual General Meeting (AGM) of the company, including information about the meeting date, voting procedures, and regulatory compliance references. It includes newspaper advertisement copies and instructions for shareholders to participate in the AGM and vote electronically. There is no substantive financial data or detailed financial performance analysis present, nor is it a transcript or management discussion. The document is not a report itself but an announcement and information dissemination about the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length and detail support this classification with high confidence.
2023-07-04 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.